John A. Josey - Net Worth and Insider Trading

John A. Josey Net Worth

The estimated net worth of John A. Josey is at least $1 Million dollars as of 2024-05-14. John A. Josey is the Director of Day One Biopharmaceuticals Inc and owns about 72,292 shares of Day One Biopharmaceuticals Inc (DAWN) stock worth over $1 Million. Details can be seen in John A. Josey's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John A. Josey has not made any transactions after 2021-06-01 and currently still holds the listed stock(s).

Transaction Summary of John A. Josey

To

John A. Josey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John A. Josey owns 1 companies in total, including Day One Biopharmaceuticals Inc (DAWN) .

Click here to see the complete history of John A. Josey’s form 4 insider trades.

Insider Ownership Summary of John A. Josey

Ticker Comapny Transaction Date Type of Owner
DAWN Day One Biopharmaceuticals Inc 2021-06-01 director

John A. Josey Latest Holdings Summary

John A. Josey currently owns a total of 1 stock. John A. Josey owns 72,292 shares of Day One Biopharmaceuticals Inc (DAWN) as of June 1, 2021, with a value of $1 Million.

Latest Holdings of John A. Josey

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DAWN Day One Biopharmaceuticals Inc 2021-06-01 72,292 16.29 1,177,637

Holding Weightings of John A. Josey


John A. Josey Form 4 Trading Tracker

According to the SEC Form 4 filings, John A. Josey has made a total of 1 transactions in Day One Biopharmaceuticals Inc (DAWN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Day One Biopharmaceuticals Inc is the acquisition of 7,000 shares on June 1, 2021, which cost John A. Josey around $112,000.

Insider Trading History of John A. Josey

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John A. Josey Trading Performance

GuruFocus tracks the stock performance after each of John A. Josey's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John A. Josey is 31.08%. GuruFocus also compares John A. Josey's trading performance to market benchmark return within the same time period. The performance of stocks bought by John A. Josey within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John A. Josey's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John A. Josey

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.78
Relative Return to S&P 500(%) 5.97

John A. Josey Ownership Network

Ownership Network List of John A. Josey

No Data

Ownership Network Relation of John A. Josey


John A. Josey Owned Company Details

What does Day One Biopharmaceuticals Inc do?

Who are the key executives at Day One Biopharmaceuticals Inc?

John A. Josey is the director of Day One Biopharmaceuticals Inc. Other key executives at Day One Biopharmaceuticals Inc include COO & CFO and Secretary York Charles N Ii , director & Chief Executive Officer Jeremy Bender , and Chief Medical Officer Samuel C. Blackman .

Day One Biopharmaceuticals Inc (DAWN) Insider Trades Summary

Over the past 18 months, John A. Josey made no insider transaction in Day One Biopharmaceuticals Inc (DAWN). Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 116,607 shares made by Samuel C. Blackman , a net sale of 150,568 shares made by Jeremy Bender , and a net sale of 106,697 shares made by York Charles N Ii .

In summary, during the past 3 months, insiders sold 225,453 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 225,453 shares. During the past 18 months, 471,785 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 2,244,684 shares were bought by its insiders, resulting in a net purchase of 1,772,899 shares.

Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Day One Biopharmaceuticals Inc Insider Transactions

No Available Data

John A. Josey Mailing Address

Above is the net worth, insider trading, and ownership report for John A. Josey. You might contact John A. Josey via mailing address: C/o Peloton Therapeutics, Inc., 2330 Inwood Road, Suite 226, Dallas Tx 75235.

Discussions on John A. Josey

No discussions yet.